Abstract: The invention relates to an infusion container comprising a sterile, ready-to-use, stable aqueous solution of Midazolam or a pharmaceutically acceptable salt thereof, suitable for direct intravenous infusion to a patient in need thereof. The invention also relates to a novel infusion container having plurality of ports that is suitable for delivering or receiving a sterile fluid, such as the said stable aqueous solution of Midazolam or a pharmaceutically acceptable salt thereof.

Abstract: The present invention relates to an intravenous infusion dosage form comprising: an aqueous solution of pemetrexed or its pharmaceutically acceptable salt at a concentration ranging from 1.0 mg/ml to 20.0 mg/ml present in a multilayered flexible plastic infusion container, wherein the multilayered flexible plastic infusion container has an oxygen scavenger layer sandwiched between an outermost and an innermost layer of the container, the container being free of a polyimide and wherein the multilayered flexible plastic infusion container filled with the aqueous solution of pemetrexed is autoclavable.

Abstract: The present invention relates to a method for enabling hospitals or clinics to administer a dose of a drug to patients in need thereof while avoiding steps of manipulation, dilution, reconstitution, dispensing, sterilization, transfer, handling or compounding before intravenous administration. The present invention further relates to a perfusion system comprising different sets of perfusion containers, each container comprising a ready-to-infuse, stable, sterile, aqueous perfusion solution of a drug, wherein the set of perfusion containers alone or in combination provides for direct intravenous administration of a desired dose of the drug to a patient in need thereof, such that the delivered dose is equal to or within ±5% of the calculated dose.

Abstract: The present invention relates to a method for enabling hospitals or clinics to administer a dose of a drug to patients in need thereof while avoiding steps of manipulation, dilution, reconstitution, dispensing, sterilization, transfer, handling or compounding before intravenous administration. The present invention further relates to a perfusion system comprising different sets of perfusion containers, each container comprising a ready-to-infuse, stable, sterile, aqueous perfusion solution of a drug, wherein the set of perfusion containers alone or in combination provides for direct intravenous administration of a desired dose of the drug to a patient in need thereof, such that the delivered dose is equal to or within ±5% of the calculated dose.

Abstract: In connection with an access of content from a cache, a snoop request can be sent to one or more remote cache devices to determine if any other cache has a copy of the content. A link between the cache and the remote cache devices can include a snoop bypass device. The snoop bypass device can monitor content cached by the one or more remote devices on a cache line or coarser granularity. The snoop bypass device can respond to the snoop request with a negative indication based on a coarser granularity tracking of content of the one or more remote cache devices.

Abstract: The invention relates to an infusion container comprising a sterile, ready-to-use, stable aqueous solution of Midazolam or a pharmaceutically acceptable salt thereof, suitable for direct intravenous infusion to a patient in need thereof. The invention also relates to a novel infusion container having plurality of ports that is suitable for delivering or receiving a sterile fluid, such as the said stable aqueous solution of Midazolam or a pharmaceutically acceptable salt thereof.

Abstract: The invention relates to an infusion container comprising a sterile, ready-to-use, stable aqueous solution of Midazolam or a pharmaceutically acceptable salt thereof, suitable for direct intravenous infusion to a patient in need thereof. The invention also relates to a novel infusion container having plurality of ports that is suitable for delivering or receiving a sterile fluid, such as the said stable aqueous solution of Midazolam or a pharmaceutically acceptable salt thereof.

Abstract: The invention relates to an infusion container comprising a sterile, ready-to-use, stable aqueous solution of Midazolam or a pharmaceutically acceptable salt thereof, suitable for direct intravenous infusion to a patient in need thereof. The invention also relates to a novel infusion container having plurality of ports that is suitable for delivering or receiving a sterile fluid, such as the said stable aqueous solution of Midazolam or a pharmaceutically acceptable salt thereof.

Abstract: The invention relates to an infusion container comprising a sterile, ready-to-use, stable aqueous solution of Midazolam or a pharmaceutically acceptable salt thereof, suitable for direct intravenous infusion to a patient in need thereof. The invention also relates to a novel infusion container having plurality of ports that is suitable for delivering or receiving a sterile fluid, such as the said stable aqueous solution of Midazolam or a pharmaceutically acceptable salt thereof.

Abstract: The invention relates to an infusion container comprising a sterile, ready-to-use, stable aqueous solution of Midazolam or a pharmaceutically acceptable salt thereof, suitable for direct intravenous infusion to a patient in need thereof.

Abstract: An example multi-master system in a system-on-chip (SoC) includes a plurality of master circuits, an error-correcting code (ECC) proxy bridge comprising hardened circuitry in the SoC, a local interconnect configured to couple the plurality of master circuits to the ECC proxy bridge, a memory not having ECC support, and a system interconnect configured to couple the ECC proxy bridge to the memory. The ECC proxy bridge is configured to establish an ECC proxy region in the memory and, for each write transaction from the plurality of master circuits that targets the ECC proxy region, calculate and insert ECC bytes into the respective write transaction.

Abstract: The invention relates to an infusion container comprising a sterile, ready-to-use, stable aqueous solution of Midazolam or a pharmaceutically acceptable salt thereof, suitable for direct intravenous infusion to a patient in need thereof. The invention also relates to a novel infusion container having plurality of ports that is suitable for delivering or receiving a sterile fluid, such as the said stable aqueous solution of Midazolam or a pharmaceutically acceptable salt thereof.

Abstract: The invention relates to an infusion container comprising a sterile, ready-to-use, stable aqueous solution of Midazolam or a pharmaceutically acceptable salt thereof, suitable for direct intravenous infusion to a patient in need thereof.

Abstract: In connection with an access of content from a cache, a snoop request can be sent to one or more remote cache devices to determine if any other cache has a copy of the content. A link between the cache and the remote cache devices can include a snoop bypass device. The snoop bypass device can monitor content cached by the one or more remote devices on a cache line or coarser granularity. The snoop bypass device can respond to the snoop request with a negative indication based on a coarser granularity tracking of content of the one or more remote cache devices.

Abstract: The present invention relates to an intravenous infusion dosage form comprising: an aqueous solution of pemetrexed or its pharmaceutically acceptable salt at a concentration ranging from 1.0 mg/ml to 20.0 mg/ml present in a multilayered flexible plastic infusion container, wherein the multilayered flexible plastic infusion container has an oxygen scavenger layer sandwiched between an outermost and an innermost layer of the container, the container being free of a polyamide and wherein the multilayered flexible plastic infusion container filled with the aqueous solution of pemetrexed is autoclavable.

Abstract: The present invention relates to a method for enabling hospitals or clinics to administer a dose of a drug to patients in need thereof while avoiding steps of manipulation, dilution, reconstitution, dispensing, sterilization, transfer, handling or compounding before intravenous administration. The present invention further relates to a perfusion system comprising different sets of perfusion containers, each container comprising a ready-to-infuse, stable, sterile, aqueous perfusion solution of a drug, wherein the set of perfusion containers alone or in combination provides for direct intravenous administration of a desired dose of the drug to a patient in need thereof, such that the delivered dose is equal to or within ±5% of the calculated dose.

Abstract: Methods and systems are disclosed for transferring data using descriptors to reference memory locations at which data is to be written to or read from. Each descriptor references a respective linked list of descriptor blocks. Each of the descriptor blocks includes a contiguous portion of the memory that stores a plurality of addresses, at which data is to be written to or read from. In response to receiving the data transfer request, a set of data is transferred from a first set of addresses specified in a first descriptor to a second set of addresses specified in a second descriptor by traversing the linked lists of descriptor blocks in the first and second descriptors.

Abstract: The present invention relates to a method for enabling hospitals or clinics to administer a dose of a drug to patients in need thereof while avoiding steps of manipulation, dilution, reconstitution, dispensing, sterilization, transfer, handling or compounding before intravenous administration. The present invention further relates to a perfusion system comprising different sets of perfusion containers, each container comprising a ready-to-infuse, stable, sterile, aqueous perfusion solution of a drug, wherein the set of perfusion containers alone or in combination provides for direct intravenous administration of a desired dose of the drug to a patient in need thereof, such that the delivered dose is equal to or within ±5% of the calculated dose.

Abstract: In an example, a circuit to manage memory between a first and second microprocessors each of which is coupled to a control circuit, includes: first and second memory circuits; and a switch circuit coupled to the first and second memory circuits, and memory interfaces of the first and second microprocessors, the switch circuit having a mode signal as input. The switch is configured to selectively operate in one of a first mode or a second mode based on the mode signal such that, in the first mode, the switch circuit couples the first memory circuit to the memory interface of the first microprocessor and the second memory circuit to the memory interface of the second microprocessor and, in the second mode, the switch circuit selectively couples the first or second memory circuits to the memory interface of either the first or second microprocessor.

Abstract: Circuits and methods are disclosed that allow devices to control the flow of DMA transfers to or from the devices using a token based protocol. In one example implementation, a DMA circuit includes a transfer control circuit that performs data transfers over a first data channel of a device, when transactions on the first data channel are enabled. The DMA circuit includes a flow control circuit that increments a token count for a data channel of a device when a token for the data channel is received and decrements the token count for each data transfer on the data channel performed by the DMA circuit. The flow control circuit enables data transfers on the data channel when the token count is greater than 0, and otherwise, disables data transfers on the data channel.